Skip to content

Clinical trial of effects of esketamine on perioperative anxiety, depression and cellular immunity in patients undergoing laparoscopic cholecystectomy

Clinical trial of effects of esketamine on perioperative anxiety, depression and cellular immunity in patients undergoing laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051969
Enrollment
Unknown
Registered
2021-10-11
Start date
2021-10-31
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety and depression

Interventions

Experimental group:Preoperative injection of esketamine 0.25mg/kg
Control group:Injection of normal saline

Sponsors

ZhuJiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged 20 to 60 years; 2.Patients with elective laparoscopic gallbladder surgery; 3.Clear consciousness, no abnormal mentality, junior high school education level or above, can independently and accurately complete the assessment of the scale; 4.American Society of Anesthesiologists (ASA) classification I-II; 5.Patients with mild to moderate anxiety and depression with a score of 11-20 on the Amsterdam Preoperative Anxiety and Information Scale (APAIS) before surgery; 6.Agree to include clinical observers.

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with anxiety disorder, depression and schizophrenia in the past; 2.Patients with APAIS score less than 10 or greater than 20 3.Patients with heart, brain, kidney, liver and other organ failure; 4.Severe language, hearing impairment and mental retardation; 5.Major intraoperative bleeding (blood volume >= 30% of systemic blood volume) is expected to occur, and vital signs are unstable; 6.Past history of immune system diseases; 7.Allergic reaction to esketamine; 8.Preoperative hypertension without drug control, severe hypertension: systolic blood pressure higher than 180mmhg.

Design outcomes

Primary

MeasureTime frame
Hospital anxiety and depression scale;Anxiety Visual Analog Scale;

Secondary

MeasureTime frame
Immune inflammatory index;Cell CD4 + / CD8 + ratio;Preoperative Amsterdam preoperative anxiety and information scale;

Countries

China

Contacts

Public ContactLiu Zhongjie

ZhuJiang Hospital of Southern Medical University

13580562690@163.com+86 13580562690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026